Cardiovascular Devices Market Size & Share, by Device Type [Diagnostic, Monitoring Devices (Electrocardiogram, Remote Cardiac Monitoring), Therapeutic, Surgical Devices {Ventricular Assist Devices (VAD), Cardiac Rhythm Management Devices, Catheters}]; Application (Coronary Artery Diseases, Cardiac Arrhythmia, Heart Failure); End-user (Hospitals, Specialty Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 3272
  • Published Date: Feb 14, 2023
  • Report Format: PDF, PPT

Companies Dominating the Cardiovascular Devices Landscape

top-features-companies
    • B Braun Melsungen AG
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Abbott
    • Johnson & Johnson Services, Inc.
    • Terumo Corporation
    • Edwards Lifesciences Corporation
    • Medtronic plc
    • Boston Scientific Corporation
    • LivaNova PLC
    • GE Group
    • Siemens Healthcare GmbH

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Abbott declared data from five late-breaking presentations showing the advantage of minimally invasive devices to treat heart diseases associated with structural diseases such as value disease or opening in the heart.  Also, the data included the findings of Mitraclip and Triclip.

  • GE Group associated with Boston Scientific Corporation to afford end-to-end innovative interventional cardiac care solutions in India. This first Medtech association is to enhance and allow easy cardiac care access to patients and thus focused on the prevailing disease burden in the country.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3272
  • Published Date: Feb 14, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing tobacco consumption and the rising obese population are the major factors driving the growth of the cardiovascular devices market.

The market is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2023-2033.

The unavailability of vendors to invest in R&D and the lack of reimbursement policies are the challenges affecting the market growth.

The market in the North American region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are B Braun Melsungen AG, Abbott, Johnson & Johnson Services, Inc., Terumo Corporation, Edwards Lifesciences Corporation, Medtronic plc, Boston Scientific Corporation, LivaNova PLC, GE Group, Siemens Healthcare GmbH.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by device type, application, end-user, and by region.

The hospital segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying